| Evaluation of RAY1225 in Adult Participants Who Have Obesity or Are Overweight (NCT06893016) | Guangdong Raynovent Biotech Co., Ltd | 2025-06-15 |
| CDK4/6 Inhibitors Combined With Standard Adjuvant Endocrine Therapy in High-Risk, HR+/HER2+ Early Breast Cancer Patients(CHESS) (NCT07019363) | Fudan University | 2025-06-15 |
| Timing of Aminophylline and Recovery in Pediatric Ambulatory Surgery (NCT07011134) | Hany Mohammed El-Hadi Shoukat Mohammed | 2025-06-15 |
| Topical Cryoanesthesia Versus Benzocaine in Pediatric Dentistry (NCT07351383) | Universidad Autonoma de San Luis Potosí | 2025-06-15 |
| A Study to Evaluate the Effect of Food or no Food on the Bioavailability of an Extended Release (ER) Torsemide and Spironolactone Fixed Dose Combination (FDC) Tablet in Healthy Adult Subjects (NCT07043634) | Sarfez Pharmaceuticals, Inc. | 2025-06-15 |
| Chemo-free in Older (≥65) Node-Positive ER+/HER2- Breast Cancer (NCT07005557) | Fudan University | 2025-06-15 |
| Bioavailability and Bioequivalence Study of Extended Release Torsemide and Spironolactone (NCT07046975) | Sarfez Pharmaceuticals, Inc. | 2025-06-15 |
| Generic Drugs (Dapagliflozin and Saxagliptin) Treat Type 2 Diabetes Patients With Controlled Cancers (NCT07033585) | Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair | 2025-06-15 |
| Study of Ravulizumab in Pediatric Participants With Primary IgAN (NCT07024563) | Alexion Pharmaceuticals, Inc. | 2025-06-14 |
| Milrinone for Prevention of Post-ligation Cardiac Syndrome Trial (NCT06679855) | NICHD Neonatal Research Network | 2025-06-13 |
| A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China (NCT06933472) | Alebund Pharmaceuticals | 2025-06-13 |
| A Study of AK112 as Consolidation Treatment for Patients With Limited Stage Small-cell Lung Cancer Who Have Not Progressed Following Concurrent Chemoradiation Therapy (NCT07010263) | Akeso | 2025-06-13 |
| Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical Trial (NCT07112144) | Changchun BCHT Biotechnology Co. | 2025-06-13 |
| Adjunctive Cannabidiol for Recovery From Opioid Study (NCT06940674) | Icahn School of Medicine at Mount Sinai | 2025-06-13 |
| A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2) (NCT06951711) | Bristol-Myers Squibb | 2025-06-13 |
| Efficacy and Safety of Maridebart Cafraglutide in Adult Participants in Japan Who Have Obesity Disease (NCT06987695) | Amgen | 2025-06-13 |
| Polypill and Colchicine for Risk Reduction in Atherosclerotic Cardiovascular Disease (NCT06930885) | Hospital do Coracao | 2025-06-12 |
| Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS2) (NCT06958211) | Incyte Corporation | 2025-06-12 |
| A Study of IBI362 in Chinese Subjects With Obstructive Sleep Apnea and BMI≥28 kg/m2 (NCT06931028) | Innovent Biologics (Suzhou) Co. Ltd. | 2025-06-12 |
| Efficacy Testing of a Multi-Level Family Planning Intervention (NCT06923189) | Boston College | 2025-06-12 |
| FMXIN002 in Patients at Risk of Anaphylaxis (NCT07045701) | Nasus Pharma | 2025-06-12 |
| Randomized Interval Assessment Trial of Lu177-Dotatate in Slowly Progressive G1-2 Advanced Midgut Neuroendocrine Tumors (NCT06878664) | Grupo Espanol de Tumores Neuroendocrinos | 2025-06-12 |
| Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant (NCT07075718) | Glaukos Corporation | 2025-06-12 |
| A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL) (NCT06943872) | BeOne Medicines | 2025-06-11 |
| Efficacy and Safety of Olokizumab in Patients With Polymyalgia Rheumatica (PROMISE) (NCT07670546) | R-Pharm International, LLC | 2025-06-11 |
| A Study to Evaluate V181 Dengue Vaccine in Healthy Participants 2 to 17 Years of Age (V181-005/MOBILIZE-1) (NCT07013487) | Merck Sharp & Dohme LLC | 2025-06-11 |
| A Phase III Study of Ivonescimab + Chemo With/Without AK117 in Metastatic Pancreatic Cancer (NCT06953999) | Akeso | 2025-06-11 |
| Efficacy and Safety of CDE100 in the Treatment of Menstrual Cramp Pain Associated With Primary Dysmenorrhea (NCT05640232) | EMS | 2025-06-11 |
| A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (NCT06951698) | Bristol-Myers Squibb | 2025-06-11 |
| A Study of HS-20137 in Participants with Moderate-to-severe Plaque Psoriasis (NCT06844799) | Hansoh BioMedical R&D Company | 2025-06-10 |
| Study of NABPLAGEM vs. Nab-Paclitaxel/Gemcitabine in BRCA1/2 or PALB2 Pancreatic Cancer (NCT06783140) | University Health Network, Toronto | 2025-06-10 |
| REVEAL: A Phase 3 Study of Obudanersen (ION582) in Angelman Syndrome (NCT06914609) | Ionis Pharmaceuticals, Inc. | 2025-06-10 |
| Shorter and Safer Treatment Regimens for Latent TB (NCT06498414) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2025-06-10 |
| Comparative PK, PD, Efficacy, and Safety Assessment of the Proposed Ocrelizumab Biosimilar CYB704 and Ocrevus in Participants With Relapsing Multiple Sclerosis (NCT06847724) | Sandoz | 2025-06-10 |
| Molecular Genetics Guide the Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation (NCT06972641) | Ruijin Hospital | 2025-06-10 |
| A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH (NCT07000136) | AstraZeneca | 2025-06-10 |
| A Study to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Japanese Adult Participants With Schizophrenia (NCT06882785) | Bristol-Myers Squibb | 2025-06-10 |
| A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer (NCT06340568) | BioNTech SE | 2025-06-10 |
| A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD (NCT07038200) | Avidity Biosciences, Inc. | 2025-06-10 |
| The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis (NCT06872892) | Boehringer Ingelheim | 2025-06-09 |
| Evaluating Cognitive Changes on Patients in Chemotherapy (ECCPC) (NCT06950190) | Ellis Medicine | 2025-06-09 |
| Bleeding Reduction in Acute and Chronic Kidney Patients Having Surgery (BRACKETS) Pilot Trial (NCT06337838) | Hamilton Health Sciences Corporation | 2025-06-09 |
| A Clinical Study of KLH-2109 in Patients With Endometriosis (NCT07015268) | Kissei Pharmaceutical Co., Ltd. | 2025-06-09 |
| A Study to Learn More About the Effects and Long-Term Safety of Omaveloxolone (BIIB141) in Children and Teens With Friedreich's Ataxia (NCT06953583) | Biogen | 2025-06-09 |
| A Study of Reduced Dose Radiation Therapy for People With B-Cell Lymphomas (NCT07029217) | Memorial Sloan Kettering Cancer Center | 2025-06-09 |
| External Mastalgia-oil Versus Placebo in Premenopausal Women With Severe Mastalgia (NCT06966245) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2025-06-08 |
| Tislelizumab Plus FOLFOX Versus POF in the Treatment of Locally Advanced: a Multicenter, Open-label, Randomized Phase III Studyunresectable or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma (NCT06793917) | Fujian Cancer Hospital | 2025-06-07 |
| The SCOPE Trial: Sleep, Cognition, and Pain Bundle vs. ERAS-cardiac for Postoperative Delirium (NCT06721819) | Beth Israel Deaconess Medical Center | 2025-06-06 |
| Intraoperative Nebulization of Lidocaine and Postoperative Pulmonary Complications (NCT07000760) | Jun Zhang | 2025-06-06 |
| Study of Salvage Therapy to Treat Patients With Granulomatosis With Polyangiitis (NCT04871191) | Assistance Publique - Hôpitaux de Paris | 2025-06-06 |
| The Effect of Erector Spinae Plane Block (ESPB) on Pediatric Pain Management Following Posterior Spinal Fusion (PSF) Surgery (NCT07561827) | University of California, San Francisco | 2025-06-06 |
| The Nordic Chronic Migraine Trial of CGRP Monoclonal Antibody and Onabotulinumtoxin A Dual Therapy Compared to CGRP mAbs Monotherapy (NCT07040813) | Oslo University Hospital | 2025-06-06 |
| A Study of BL-M07D1 With or Without Pertuzumab Versus Taxane + Trastuzumab and Pertuzumab in Neoadjuvant Therapy for HER2-Positive Breast Cancer (NCT06891833) | Sichuan Baili Pharmaceutical Co., Ltd. | 2025-06-05 |
| High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer (NCT06992427) | Alliance for Clinical Trials in Oncology | 2025-06-05 |
| A Safety and Immunogenicity Study of CHIKV VLP Vaccine in Children. (NCT07003984) | Bavarian Nordic | 2025-06-05 |
| A Study to Evaluate Axatilimab Versus Best Available Therapy in Participants With Chronic Graft Versus Host Disease After at Least 2 Prior Lines of Systemic Therapy (NCT06821542) | Incyte Corporation | 2025-06-04 |
| A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) (NCT06852222) | Janssen Research & Development, LLC | 2025-06-04 |
| A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event (NCT07000357) | AstraZeneca | 2025-06-04 |
| A Study of MHB088C Injection Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer (NCT06954246) | Qilu Pharmaceutical Co., Ltd. | 2025-06-04 |
| No Axillary Surgical Treatment in Clinically Lymph Node Negative Patients on Ultrasonography After Neoadjuvant Chemotherapy (NCT06704945) | Seoul National University Hospital | 2025-06-04 |
| A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome (NCT06872125) | Stoke Therapeutics, Inc | 2025-06-04 |
| Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION) (NCT06891443) | Laboratoires Thea | 2025-06-04 |
| A Trial of HRS-5965 Capsule in Primary IgA Nephropathy (NCT07014826) | Chengdu Suncadia Medicine Co., Ltd. | 2025-06-04 |
| Standard-of-care Systemic Therapy With or Without Local Therapy in Patients With Oligoprogressive Non-Small Cell Lung Cancer(NSCLC） (NCT07076693) | Shanghai Chest Hospital | 2025-06-03 |
| Comparison Between a Rush and a Conventional Oral Immunotherapy Protocol to Treat Cow's Milk and Hen´s Egg Allergy. CompITO Study (NCT06976775) | Pablo Rodríguez del Rio | 2025-06-03 |
| RECURrence of Atrial Fibrillation After Cardioversion of Patients Randomized to Dapagliflozin or Usual Care (NCT07187570) | Region Stockholm | 2025-06-03 |
| Omitting CTV for Primary Tumor in LS-SCLC (NCT07008716) | Sun Yat-sen University | 2025-06-03 |
| A Study of BL-M07D1 Versus T-DM1 in the Adjuvant Treatment of HER2-positive Breast Cancer With Residual Invasive Cancer After Neoadjuvant Therapy (NCT06830889) | Sichuan Baili Pharmaceutical Co., Ltd. | 2025-06-03 |
| A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-term (NCT07011667) | Novo Nordisk A/S | 2025-06-03 |
| C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV (NCT07037277) | Atea Pharmaceuticals, Inc. | 2025-06-02 |
| Dexmedetomidine, Magnesium Sulphate and Lidocaine for Cough Suppression After General Anesthesia (NCT06979141) | Al-Azhar University | 2025-06-02 |
| Adjunctive Methylene Blue in Septic Shock (NCT06900140) | Dr. Shannon M. Fernando | 2025-06-02 |
| Chemotherapy Omission in HR-positive/HER2-negative Breast Cancer With Lymph Node Negative Disease Receiving Adjuvant Endocrine Therapy and CDK4/6 Inhibitor (NCT06996093) | Fudan University | 2025-06-02 |
| Optimal Timing of Hepatitis B Vaccination After Transplants (NCT06888479) | Institute of Hematology & Blood Diseases Hospital, China | 2025-06-01 |
| A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE) (NCT06568627) | MediWound Ltd | 2025-06-01 |
| Investigation of Growth Hormone and Platelet-Rich Plasma on Joint Health (NCT06907121) | Integrant Pty Ltd | 2025-06-01 |
| Japanese Bridging Study of Autologous Muscle Derived Cells Compared to Placebo for Female Urinary Sphincter Repair(JPN1) (NCT03997318) | Cook MyoSite | 2025-06-01 |
| Comparison of Alpha Blockers (Terazosin and Tamsulosin) in Reducing Ureteral Stent Related Symptoms (NCT06966804) | Penang Hospital, Malaysia | 2025-06-01 |
| Assessing Tenapanor as a Treatment of CF-related Constipation. (NCT06810167) | Massachusetts General Hospital | 2025-06-01 |
| A Phase III Study of SYHX1901 Tablets in the Treatment of Moderate to Severe Plaque Psoriasis (NCT06943950) | CSPC Ouyi Pharmaceutical Co., Ltd. | 2025-06-01 |
| Effectiveness of Medium-Dose Cytarabine Combined With Venetoclax for Consolidation Therapy in Elderly Patients With Intermediate to High-Risk Acute Myeloid Leukemia (NCT06990321) | Yehui Tan | 2025-06-01 |
| Comparison of Dexmedetomidine and Dexamethasone for the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Cholecystectomy (NCT07426081) | Patel Hospital, Pakistan | 2025-06-01 |
| Efficacy, Safety, and Pharmacokinetics of FP-014, 22.5 mg in Patients With Advanced Prostate Cancer (NCT06795191) | Foresee Pharmaceuticals Co., Ltd. | 2025-06-01 |
| LIGHT Trial: Levothyroxine for Gestational Hypothyroidism in Recurrent Pregnancy Loss (NCT06999278) | Women's Hospital School Of Medicine Zhejiang University | 2025-06-01 |
| Comparison of Otezla to SFA-002 to Placebo in Plaque Psoriasis Patients (NCT06863493) | SFA Therapeutics | 2025-06-01 |
| Multi-strain Probiotics to Prevent Necrotizing Enterocolitis in Very Preterm Infants (NCT06810154) | University of Calgary | 2025-06-01 |
| Efficacy Test of Curcuminoid Standardized Turmeric Capsules to Improving Inflammatory Biomarkers in Osteoarthritis Genu (NCT07183215) | Gadjah Mada University | 2025-06-01 |
| Multicenter Study of Combined Chemotherapy and Transplantation for Adult ALL (NCT07059156) | Shanxi Bethune Hospital | 2025-06-01 |
| Early Use of Realgar-Indigo Naturalis Formula (RIF) Combined With All-trans Retinoic Acid (ATRA) for Treating Acute Promyelocytic Leukemia (APL). (NCT07503730) | First Affiliated Hospital Xi'an Jiaotong University | 2025-06-01 |
| Cefepime-taniborbactam vs Meropenem in Adults With VABP or Ventilated HABP (NCT06168734) | Venatorx Pharmaceuticals, Inc. | 2025-06-01 |
| Highly Aspherical Lenslet (HAL) and Binocular Vision (BV) Disorders [HALT X(T) Study] (NCT06863675) | Singapore National Eye Centre | 2025-06-01 |
| Ultrasound-Guided Stellate Ganglion Block in Fibromyalgia (NCT07343128) | Sanliurfa Education and Research Hospital | 2025-06-01 |
| A Phase 3 Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and Efficacy (NCT06643260) | Can-Fite BioPharma | 2025-06-01 |
| Clinical Study on Nanocrystalline Megestrol Acetate for Appetite Improvement and Weight Gain in Pre-Cachexia and Cachexia Stages Key Terminology Analysis (NCT06961188) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2025-06-01 |
| Clinical Trial to Investigate the Efficacy and Safety of Ondansetron (Danset - Adwia) Versus Placebo Plus the Standard of Care in the Treatment of Nausea and Vomiting in Adult Patients With Acute Gastroenteritis (NCT05876585) | Genuine Research Center, Egypt | 2025-06-01 |
| New Triple Therapy in Newly Diagnosed Type 2 Diabetes (NCT06946628) | Sun Yat-sen University | 2025-06-01 |
| The Use of Indocyanine Green Near-infrared Fluorescence for Bowel Perfusion Quantitative Assessment in Order to Prevent Anastomotic Leakage in Colorectal Surgery (NCT06845306) | Vadim Kuznetsov | 2025-06-01 |
| Telemedicine XR-B for Individuals in Jail (NCT07524738) | Friends Research Institute, Inc. | 2025-06-01 |
| The Effect of Vitamin D Supplement as Adjuvant Therapy in Eradication of Helicobacter Pylori Infection (NCT06964334) | Assiut University | 2025-06-01 |
| Dose-modified Emapalumab and Ruxolitinib (E-Ru) Regimens for Hemophagocytic Lymphohistiocytosis (NCT06951971) | The First Affiliated Hospital of Soochow University | 2025-06-01 |